# Dov Szapiro

> Dov Szapiro is a Series A investor at Entourage Effect Capital backing Cannabis and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Entourage Effect Capital](https://shizune.co/investors/profile/entourage-effect-capital)
- Location: Miami, United States
- Total investments: 2
- Last investment: Apr 2023
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/dov-szapiro-51257/
- Website: https://www.crescocapitalpartners.com

Dov Szapiro is a Series A investor at Entourage Effect Capital in Miami focused on Cannabis and Health Care. Dov Szapiro is the Co-Founder and Co-Managing Partner at Entourage Effect Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Cannabis | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |
| Alternative Medicine | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cookies | Cookies Inc., is a cannabis brand, which currently has 7 dispensaries in California, 1 in Detroit. |  | Series A | Apr 11, 2023 |  |
| Hound Labs | Hound Labs is a breath technology company that has developed ultra-sensitive technology for non-invasive breath measurement. Utilizing this groundbreaking technology, the HOUND MARIJUANA BREATHALYZER is the world’s first breathalyzer to rapidly, accurately, and inexpensively measure recent marijuana use and alcohol in a person’s breath. The HOUNDBREATHALYZER is intended for law enforcement, employer, and insurance purposes only. Founded in 2014, the Oakland-based company was created by Dr. Mike Lynn, an ER physician, reserve deputy sheriff, and former venture capitalist, his co-founder, Mr. Kuni Oh, a patent attorney with a deep background in engineering and science, and his co-founder, Ms. Jenny Lynn, a business executive with twenty years of experience launching new ventures. Benchmark, Icon Ventures, Intrinsic Capital Partners, Main Street Advisors, NFP Ventures, and individual investors have funded the Company. | $20M | Venture - Series Unknown | Sep 03, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [12/12 Ventures](https://shizune.co/investors/profile/12-12-ventures) — VC Fund, 1 deal together
- [Benchmark](https://shizune.co/investors/profile/benchmark) — VC Fund, 1 deal together
- [Icon Ventures](https://shizune.co/investors/profile/iconventures) — VC Fund, 1 deal together
- [Intrinsic Capital Partners](https://shizune.co/investors/profile/intrinsic-capital-partners) — VC Fund, 1 deal together
- [Tuatara Capital](https://shizune.co/investors/profile/tuatara-capital-lp) — VC Fund, 1 deal together

## About Entourage Effect Capital

VC Fund

Entourage Effect Capital, LLC (formerly Cresco Capital Partners, LLC) is a private investment firm, dedicated to investing in the cannabis industry. EEC’s mission is to actively leverage our sector and investment experience, networks, and investment process, and to identify, invest and accelerate high quality emerging growth companies. EECstands apart by taking an active role in adding value to the management teams of its companies. Some have called it a “Keiretsu”, but as we are in Cannabis, we call it “the Entourage Effect.” The Entourage Effect is a term used to describe a novel method of endocannabinoid regulation. It means that the compounds within the cannabis plant work in concert to create a sum greater than any of its individual parts. This is the same strength they bring to investing. From early stage acceleration, to acquisition sourcing, to strategy, to creating exit opportunities, they believe in being the most valuable names on their founder’s cap tables.

3 contacts available at Entourage Effect Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Dov Szapiro | Co-Founder I Co-Managing Partner | https://shizune.co/investors/profile/dov-szapiro |
| Matt Hawkins | Founder & Managing Partner | https://shizune.co/investors/profile/matt-hawkins-1569 |
| Andrew Sturner | Co-Founder & Managing Partner | https://shizune.co/investors/profile/andrew-sturner |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Dov Szapiro invest in?

Dov Szapiro invests primarily in Cannabis, Health Care and Biotechnology startups, most often at Series A and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dov Szapiro last invest?

The most recent investment recorded for Dov Szapiro closed in Apr 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co